Overview

IndusCann is a Indian Medical Cannabis Research company that is actively engaged in clinical trials (Cancer, Epilepsy and Sickle Cell anemia) and medical studies on humans and animals. With exclusive partnership with leading Indian Research Institutes and Hospitals, IndusCann is developing considerable expertise with Indian genetics from Kush and Himalayan regions enabling the development of new cultivars with specific traits for the clinical trials. Headquartered in Toronto, Canada and with Industry leading Science and R&D team from Canada, Spain and India approaching 20+ PhDs the company is developing new products and integrating exciting innovations from leading research institutes and universities from US, Europe and Canada along with Indian counterparts. With these combined capabilities, the company looking to accelerate product development for the broader Indian medical market. 617 millions Indians suffer from a disease that medical cannabis can treat and effectively alleviate symptoms as an alternative or even primary remedy. IndusCann is committed in bringing affordable medicine to the broader Indian population.